Article

VGF in cerebrospinal fluid, when combined with conventional biomarkers, enhances prediction of conversion from mild cognitive impairment to Alzheimer’s Disease

2019-01-07

Abstract excerpt

Sensitive and accurate biomarkers for the prediction of conversion from mild cognitive impairment (MCI) to Alzheimer’s Disease (AD) are needed to both support clinical care and enhance clinical trial design. Here, we examined the potential of cerebrospinal fluid (CSF) levels of a peptide derived from a neural protein involved in synaptic transmission, VGF (a non-initialism), to enhance accuracy of prediction of co...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 7fd4ad95-c641-541d-9fd0-b03f43e0334c
DOI: 10.1101/512939

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

VGF in cerebrospinal fluid, when combined with conventional biomarkers, enhances prediction of conversion from mild cognitive impairment to Alzheimer’s DiseaseDOI 10.1101/512939Read

Cerebrospinal fluid biomarker panel for synaptic dysfunction in a broad spectrum of neurodegenerative diseasesSemantic proximity Read

VGF as a biomarker and therapeutic target in neurodegenerative and psychiatric diseasesSemantic proximity Read

Extracellular Vesicles for Alzheimer’s Disease and Dementia DiagnosisSemantic proximity Read

Cerebrospinal fluid neurogranin concentration in neurodegeneration: relation to clinical phenotypes and neuropathology.Semantic proximity Read

An Integrated Workflow for Multiplex CSF Proteomics and Peptidomics—Identification of Candidate Cerebrospinal Fluid Biomarkers of Alzheimer’s DiseaseSemantic proximity Read

Nonlinear biomarker interactions in conversion from Mild Cognitive Impairment to Alzheimer’s diseaseSemantic proximity Read

Cerebrospinal fluid neurochemical phenotypes in vascular dementias: original data and mini-review.Semantic proximity Read

Prediction of Alzheimer's disease using a cerebrospinal fluid pattern of C-terminally truncated beta-amyloid peptides.Semantic proximity Read

Cerebrospinal fluid profile in frontotemporal dementia and Alzheimer's disease.Semantic proximity Read

Association of Clusterin Levels in Cerebrospinal Fluid with Synaptic Degeneration Across the Alzheimer’s Disease ContinuumSemantic proximity Read

The Associations of Serum Valine with Mild Cognitive Impairment and Alzheimer’s DiseaseSemantic proximity Read

Cerebrospinal Fluid Cyclase-associated protein 2 is increased in Alzheimer’s disease and correlates with tau pathologySemantic proximity Read